ラクオリア創薬(株)の貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|
| 東証GRT | 医薬品 | 4579/E25269 | RaQualia Pharma Inc. |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|
| 2013/03/01 | 日証協 | 207,786株 | +26.31% | 110,686株 | +71.61% | 148,907株 | +29.13% | 134,295株 | +1934.77% |
| 2013/02/22 | 日証協 | 164,500株 | -21.15% | 64,500株 | +109.87% | 115,312株 | -26.79% | 6,600株 | -44.58% |
| 2013/02/15 | 日証協 | 208,616株 | -2.87% | 30,733株 | +122.7% | 157,512株 | +5.92% | 11,910株 | -76.04% |
| 2013/02/08 | 日証協 | 214,783株 | +3.77% | 13,800株 | 0% | 148,702株 | -0.67% | 49,700株 | +197.6% |
| 2013/02/01 | 日証協 | 206,983株 | -2.62% | 0株 | -100% | 149,702株 | -7.72% | 16,700株 | +35.66% |
| 2013/01/25 | 日証協 | 212,550株 | +1.56% | 86,583株 | +563.01% | 162,222株 | +5.19% | 12,310株 | +0.08% |
| 2013/01/18 | 日証協 | 209,291株 | +1.6% | 13,059株 | +31.91% | 154,212株 | -3.5% | 12,300株 | -19.08% |
| 2013/01/11 | 日証協 | 205,991株 | -1.76% | 9,900株 | +989.11% | 159,812株 | +2.44% | 15,200株 | +2940% |
| 2013/01/04 | 日証協 | 209,682株 | +4.76% | 909株 | -90.45% | 156,011株 | +4.14% | 500株 | -94.19% |
| 2012/12/28 | 日証協 | 200,163株 | -0.1% | 9,519株 | -82.93% | 149,811株 | -4.4% | 8,601株 | +24.65% |
| 2012/12/21 | 日証協 | 200,363株 | +0.41% | 55,763株 | 0% | 156,712株 | +2.39% | 6,900株 | +294.06% |
| 2012/12/14 | 日証協 | 199,550株 | -3.25% | 0株 | -100% | 153,061株 | -1.51% | 1,751株 | -46.94% |
| 2012/12/07 | 日証協 | 206,250株 | +6.7% | 12,600株 | +394.12% | 155,411株 | +0.06% | 3,300株 | -21.62% |
| 2012/11/30 | 日証協 | 193,300株 | -2.23% | 2,550株 | -94.83% | 155,311株 | -4.78% | 4,210株 | -32.1% |
| 2012/11/22 | 日証協 | 197,700株 | -8.85% | 49,300株 | +42.9% | 163,101株 | 0% | 6,200株 | -23.46% |
| 2012/11/16 | 日証協 | 216,900株 | +66.08% | 34,500株 | -76.98% | 163,101株 | +46.28% | 8,100株 | -93.16% |
| 2012/11/09 | 日証協 | 130,600株 | +198% | 149,875株 | 0% | 111,501株 | +74.22% | 118,500株 | +3191.67% |
| 2012/11/02 | 日証協 | 43,825株 | -4.36% | 0株 | -100% | 64,001株 | +0.95% | 3,600株 | +140% |
| 2012/10/26 | 日証協 | 45,825株 | +4.56% | 2,000株 | +42.86% | 63,401株 | +1.6% | 1,500株 | -57.14% |
※株式分割は考慮していませんのでご注意ください。
Page Top